Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney

CE Sexton; KJ Anstey; F Baldacci; CJ Barnum; AM Barron; K Blennow; H Brodaty; S Burnham; FM Elahi; J Götz; YH Jeon; M Koronyo-Hamaoui; SM Landau; NT Lautenschlager; SM Laws; DM Lipnicki; H Lu; CL Masters; W Moyle; A Nakamura; GM Pasinetti; N Rao; C Rowe; PS Sachdev; PR Schofield; EM Sigurdsson; K Smith; V Srikanth; C Szoeke; MG Tansey; R Whitmer; D Wilcock; TY Wong; LJ Bain; MC Carrillo

Journal article

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney

CE Sexton, KJ Anstey, F Baldacci, CJ Barnum, AM Barron, K Blennow, H Brodaty, S Burnham, FM Elahi, J Götz, YH Jeon, M Koronyo-Hamaoui, SM Landau, NT Lautenschlager, SM Laws, DM Lipnicki, H Lu, CL Masters, W Moyle, A Nakamura Show all

Alzheimer S and Dementia | WILEY | Published : 2022

DOI: 10.1002/alz.12380

Abstract

The Alzheimer's Association International Conference held its sixth Satellite Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian researchers in advancing the understanding of and treatment developments for Alzheimer's disease (AD) and other dementias. This leadership includes the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL), which has fueled the identification and development of many biomarkers and novel therapeutics. Two multimodal lifestyle intervention studies have been launched in Australia; and Australian researchers have played leadership roles in other global studies in diverse populations. Australian researchers have also..

View full abstract

University of Melbourne Researchers

Nicola Lautenschlager Author

Christopher Rowe Author

Cassandra Szoeke Author

Related Projects (5)

A randomised controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline

Thirteen percent of all cases with Alzheimer’s Disease are potentially due to a lack of physical activity. This study investigates whether a..

A RANDOMISED CLINICAL TRIAL OF PHYSICAL ACTIVITY TO DELAY THE PROGRESSION OF CEREBROVASCULAR PATHOLOGY

The aim of this randomised clinical trial is to establish whether a 24 months physical activity (PA) program for older adults with memory pr..

CENTRES FOR RESEARCH EXCELLENCE IN PROMOTING COGNITIVE HEALTH AND PREVENTING COGNITIVE DECLINE

Cognitive health is essential for productivity at all ages. Common chronic diseases such as diabetes, and risk factors such as smoking, can ..

MODIFIABLE RISK FACTORS FOR COGNITIVE IMPAIRMENT IN AGEING

This study focuses on age-related decline in cognitive function in midlife.Early detection of people at risk will allow the introduction of ..

WOMEN'S HEALTHY AGEING COGNITIVE PROJECT

The changes of Alzheimer’s disease occur a decade prior to symptoms. Therefore we need longitudinal prospective data over 20 years to determ..

Grants

Awarded by Alzheimer's Association

Funding Acknowledgements

National Health and Medical Research Council, Grant/Award Numbers: 1100579, 1102694, 1156891, 1161706, 1191535, 1005942, 1045530, 1100579; Nanyang Technological University Singapore; Alzheimer's Association, Grant/Award Numbers: AARG-18-566427, NIRG-14-320312; Singapore Ministry of Education, Grant/Award Number: 2018-T1-001-041; the Swedish Research Council, Grant/Award Number: #2017-00915; Alzheimer Drug Discovery Foundation (ADDF), USA, Grant/Award Number:#RDAPB-201809-2016615; SwedishAlzheimer Foundation, Grant/Award Number: #AF-742881; Hjarnfonden, Sweden, Grant/Award Number: #FO2017-0243; European Union Joint Program for Neuro degenerative Disorders, Grant/Award Number: JPND2019-466236; National Health and Medical Research Council ofAustralia, Grant/Award Numbers: APP1095097, 1093083; New Vision Research Investigator Award, Grant/Award Number: CCAD201903; Larry L. Hillblom Foundation, Grant/Award Number: 2019-A-012-SUP; National Institute onAging, Grant/Award Numbers: R01AG055865, R01AG056478, R01AG062542, R01AG062689, U19 AG024904; The Dementia Momentum Fund, Grant/Award Number: PS38235; National Institutes of Health, Grant/AwardNumbers: UH3NS100588, R01AG064792, R01 NS077239, R01AG032611, R21AG059391, R21AG058282